Skipping a dose or reducing dose is never a failureit reflects smart individualization of your protocol
A promising therapeutic approach being studied uses IGF-1 analogues such as PEG-IGF-1 [263], which offers promising protection against acute contraction-induced muscle injury
As a dual GIP and GLP-1 receptor agonist, Tirzepatide works by targeting multiple pathways in the body that regulate blood sugar, appetite, and fat storage
If you ask any woman who's on bioidentical hormone replacement if she wants to stay on it forever, she'll tell you yes
Research shows that for every 1,000 people that are at risk of heart problems, if those people take a statin for three years, statins will prevent: 7 non-fatal heart attacks 4 strokes 2 deaths This means that nearly 99% of people will not benefit from statins, however, because 1% of people do benefit, this means that considering there are around 17.5 million people in the UK that are at risk of heart problems, thousands of heart attacks, strokes and death could be prevented
Kidney Int 80(3):282287 Funding The study medication was provided by Boehringer Ingelheim
